Replies to post #230402 on Innovation Pharmaceuticals Inc (IPIX)

[frrol]

There is a possible downside: we have opex and don't know if there's more $.25 issuances or for how long. The meter is now running fast. The speed of a B deal and a (good) P results release is now a higher imperative.

[Amatuer17]

“If the data comes in Q3 - so be it”

What can you do anyway?

It did not come in Q4-2017 - what did you do? Nothing
What control you had - nothing

It did not come in Q1-2018 - again what did you do - nothing

So what will be different this time - nothing

But it does not mean that all investors should keep blind faith and should not ask questions or guess some bad signs
As good SH - our job is to ask questions even if others call us as shorts.

[To infinity and beyond!]

Don't worry be happy! This is so correct!

Like if you are on a sinking ship and then you panic, how does that help? Isn't it much better to pretend the boat is fine and then there is no reason to panic? Or worry?

Those things just activate your sympathetic responses and raise blood pressure etc. And who needs that?
When you can just say there is no problem with the P2b data release?

Got it: no worries mate

[kfcyahoo]

"I don't see any negatives to the company from missing the Q2 expected release of interim data from the P2B trial. I don't think any longs are going to be selling and certainly no institutional selling since we basically have no institutional holdings(IH)."

If the bus driver blows through another bus stop(Q2, 2018) with out a word, or another meek excuse without advising us when the bus will stop, I'm sure someone will advise authorities that this bus has been hijacked or the driver is possibly experiencing a hypoglycemic reaction.

Regarding your belief there will be no institutional selling- I agree- other than the sole IH which holds~ 300 shares, who could sell.